Neuren Pharmaceuticals | NEU - Market Capitalization


Neuren Pharmaceuticals reported AUD2.67B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 427M 297M Dec/2025
Alaunos Therapeutics USD 7M 2M Mar/2026
Avita Medical AUD 105.47M 35.32M Dec/2025
Clinuvel Pharmaceuticals AUD 625.5M 105.22M Dec/2025
Dianthus Therapeutics USD 4.58B 2.8B Mar/2026
Genetic Signatures AUD 56.78M 26.12M Dec/2025
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
Medical Developments International AUD 62.53M 563.29K Dec/2025
Neuren Pharmaceuticals AUD 2.36B 606.56M Dec/2025
Organon & Co USD 3.56B 1.99B Jun/2026
Paradigm Biopharmaceuticals AUD 145.7M 26.92M Dec/2025
PYC Therapeutics AUD 965.3M 209.97M Dec/2025
Tectonic Therapeutic USD 580M 190M Mar/2026
Telix Pharmaceuticals AUD 7.81B 2.74B Jun/2026
Viatris USD 18.49B 2.76B Jun/2026
Xeris Pharmaceuticals USD 1000M 303M Mar/2026